Recent Finacing
Recent Raise
Sail Biomedicines develops RNA-based programmable medicines using Endless RNA circular technology and programmable nanoparticles to enable prolonged expression of complex biologics, employing rapid prototyping, testing bioplatforms, and AI-driven design.
